Siensmetrica Appoints Former Wiley CEO Brian Napack to Advisory Board

TUCSON, Ariz., Sept. 16, 2026 /PRNewswire/ -- Siensmetrica, Inc., developer of the AI-powered research analysis platform Tessa, today announced the appointment of Brian Napack to its Advisory Board. Napack brings decades of executive leadership and innovation at the intersection of science, education, and tech-enabled information services.

Napack has long been a leader in the education, scientific research, and information industries. He is the former CEO of John Wiley (WLY), one of the world's leading research and education publishers, and providers of technology-enabled services that make science and education more productive. He is an active director, advisor and investor, and currently serves as Executive Chairman of 2U, Director of RB Media, and Director of Elentra.

He has served as President of Macmillan, the global publisher; Chairman of the Association of American Publishers; Senior Advisor at Providence Equity, a leading media and education investor; Partner at L.E.K. Consulting and co-head of its media practice; and founder and CEO of ThinkBox, a digital-education company. Napack founded Disney Educational Publishing and co-founded Disney Interactive. He has served on many boards including Houghton Mifflin Harcourt, Blackboard, the Business-Higher Education Forum, Burning Glass, Ascend Learning, Recorded Books, Ingram Industries, myON/Renaissance Learning, EDMC, and Synergis/Risepoint. He holds a bachelor's degree from Middlebury College and an MBA from Columbia University.

"Brian's background reaches nearly every corner of how research and knowledge get published, evaluated, and trusted," said Marc Toth, CEO of Siensmetrica. "As Tessa scales to bring transparency and rigor to biomedical research evaluation, his experience navigating that ecosystem will directly affect how we enhance the technology for the people who rely on us."

Siensmetrica's flagship platform, Tessa, analyzes scientific literature across nearly 200 methodological and contextual data points. By generating standardized trustworthiness metrics (TScores) and deep-dive analytical frameworks, Tessa enables researchers, clinicians, policymakers, and biopharma leaders to quickly differentiate high-integrity evidence from flawed methodology.

"The accelerating pace of scientific discovery presents a huge opportunity to advance human progress, but it also presents a major challenge for the research-intensive industries: how to sort through the unprecedented volume of published research to find the best, most relevant information to advance their work," said Napack. "Tessa is accelerating innovation and problem solving by helping research consumers quickly and confidently sort strong evidence and conclusions from weak ones. I'm glad to be working with this team as they build a better way to evaluate scientific research."

About Siensmetrica
Siensmetrica's mission is to help medical and scientific professionals deliver better care and accelerate discoveries by quickly and easily identifying high-quality, trustworthy research. The company's Tessa platform uses a proprietary framework — Transparency, Explainability, and Significance (T.E.S.) — to evaluate biomedical literature across nearly 200 data points, producing clear objective scores, deep-dive domain analyses, and interactive research visualizations. Learn more at https://www.siensmetrica.com or contact [email protected].

Contact
Sage Osterfeld
[email protected] 
tel: (760) 593-7243

SOURCE Siensmetrica, Inc.